Assurance Infusion Recalls QUADMIX FORTE Vials Due to Sterility Concerns
Assurance Infusion is recalling QUADMIX FORTE in 1 mL vials because of a lack of sterility assurance. The recall covers 5 vials distributed nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, FDA Class II recalls with potential for significant injury or hospitalization are rated as Severe (4).
Plain-English summary
Assurance Infusion is recalling QUADMIX FORTE in 1 mL vials due to a lack of sterility assurance. The recall involves 5 vials with Lot 08132019@15 and an expiration date of 02/09/2020.
The product was distributed nationwide within the United States. The recall is classified as FDA Class II, indicating a reasonable probability that use of the product could cause temporary or medically reversible health consequences.
Consumers and healthcare providers should stop using the affected vials and contact Assurance Infusion at (713) 533-8800 for further instructions.
The recalled product
- Product
- QUADMIX FORTE in 1 mL vial Assurance Infusion (713) 533-8800
- Manufacturer
- Assurance Infusion
- Category
- Drug — Infusion Solution
- Hazard
- Affected units
- 5
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 08132019@15 Exp. 02/09/2020
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 118 recalled by Assurance Infusion under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 118 products in this recall →Related recalls
Same manufacturer · Assurance Infusion
See all →- SevereAssurance Infusion Recalls Buprenorphine and Hydromorphone Injection Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
- SevereAssurance Infusion Recalls Hydromorphone Injection Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
- SevereAssurance Infusion Recalls Fentanyl Syringes Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
- SevereAssurance Infusion Recalls Morphine Injection Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
- SevereAssurance Infusion Recalls Buprenorphine and Morphine Injection Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- SevereQuadMix Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2013-05-01
- SevereFDA Recalls Quadmix Custom Injectable Due to Sterility Assurance Concerns
FDA (Drugs) · 2013-05-01
- HighFDA Recalls QUAD-MIX Injectable for Sterility Assurance Failure
FDA (Drugs) · 2022-09-21
- SevereBiMix Plus Injectable Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2013-05-01
- HighFDA Recalls Injectable Medication Due to Sterility Assurance Failure
FDA (Drugs) · 2022-09-21
- SevereWalgreens Recalls Diphenhydramine Vials Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-01-28